About HCC CONNECT
HCC CONNECT is a multidisciplinary group of international experts in liver oncology with a particular focus on hepatocellular carcinoma (HCC) who develop educational programmes, supporting healthcare professionals around the world to give the best possible care to their patients. We aim to create a forum to discuss the latest scientific and clinical insights and share best practices from International Centres of Excellence in liver oncology.
Please submit your clinical topic for the next HCC CONNECT newsletter.
Subscribe to the HCC CONNECT newsletter to receive monthly updates.
Sequential sorafenib and regorafenib in patients with advanced HCC
Dr. Mohamed Bouattour discusses the recently published additional analyses from the phase 3 RESORCE trial on sequential treatment with sorafenib followed by regorafenib for hepatocellular carcinoma.